Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.

Shih IM, Yu J, He TC, Vogelstein B, Kinzler KW.

Cancer Res. 2000 Mar 15;60(6):1671-6.

2.
3.

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.

Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y.

Nat Genet. 2000 Mar;24(3):245-50.

PMID:
10700176
4.

Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.

Sekiya T, Nakamura T, Kazuki Y, Oshimura M, Kohu K, Tago K, Ohwada S, Akiyama T.

Cancer Res. 2002 Jun 1;62(11):3322-6.

5.

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW.

Science. 1997 Mar 21;275(5307):1787-90.

6.

A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.

Wakita K, Tetsu O, McCormick F.

Cancer Res. 2001 Feb 1;61(3):854-8.

7.

Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.

Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER.

Cell Growth Differ. 1999 Jun;10(6):369-76.

8.

Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells.

Sekiya T, Adachi S, Kohu K, Yamada T, Higuchi O, Furukawa Y, Nakamura Y, Nakamura T, Tashiro K, Kuhara S, Ohwada S, Akiyama T.

J Biol Chem. 2004 Feb 20;279(8):6840-6. Epub 2003 Dec 1.

9.

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

Tetsu O, McCormick F.

Nature. 1999 Apr 1;398(6726):422-6.

PMID:
10201372
10.

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.

Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H.

Science. 1997 Mar 21;275(5307):1784-7.

11.

Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription.

Rosin-Arbesfeld R, Cliffe A, Brabletz T, Bienz M.

EMBO J. 2003 Mar 3;22(5):1101-13.

12.

Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients.

Kohler EM, Brauburger K, Behrens J, Schneikert J.

Oncogene. 2010 Mar 18;29(11):1663-71. doi: 10.1038/onc.2009.447. Epub 2009 Dec 7.

PMID:
19966865
13.
14.

Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.

Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P.

Curr Biol. 1998 May 7;8(10):573-81.

15.

Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.

Araki Y, Okamura S, Hussain SP, Nagashima M, He P, Shiseki M, Miura K, Harris CC.

Cancer Res. 2003 Feb 1;63(3):728-34.

16.

APC 3 x 15 beta-catenin-binding domain potentiates beta-catenin association to TBP and upregulates TCF-4 transcriptional activity.

Roura S, Martínez D, Piedra J, Miravet S, García de Herreros A, Duñach M.

Biochem Biophys Res Commun. 2003 Oct 3;309(4):830-5.

PMID:
13679048
17.

Identification of c-MYC as a target of the APC pathway.

He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW.

Science. 1998 Sep 4;281(5382):1509-12.

18.

Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.

Faux MC, Ross JL, Meeker C, Johns T, Ji H, Simpson RJ, Layton MJ, Burgess AW.

J Cell Sci. 2004 Jan 26;117(Pt 3):427-39. Epub 2003 Dec 16.

19.

Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.

Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR, Fearon ER.

J Biol Chem. 2002 Jun 14;277(24):21657-65. Epub 2002 Apr 8.

20.

Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas.

Venesio T, Balsamo A, Scordamaglia A, Bertolaso M, Arrigoni A, Sprujevnik T, Rossini FP, Risio M.

Mod Pathol. 2003 Jan;16(1):57-65.

Supplemental Content

Support Center